Service positioning

Mapping technical requirements and business models for a differentiated biomarker service.

Enabling technologies

The MILAN platform belongs to LISCO, the KU Leuven Institute for Single Cell Omics. MILAN – Multiple Iterative Labeling by Antibody Neodeposition – is an automated immunofluorescence-based multiplex platform for advanced biomarker research at the single-cell level.

I was asked to screen pharma and biotech industry interest in the MILAN platform as a service for advanced biomarker research. Through Voice of the Customer interviews and additional desk research, I mapped market interest, minimal viable technical requirements and the competitive service landscape.

Finally, I estimated the global market potential, suggested pricing and developed potential business models.

 

Like what I did here? Let’s get in touch.

Call +32 476 85 38 76 or Send me an email

More background info? Read my resume.